Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease
Open Access
- 1 March 2015
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 107, 75-81
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Economía y Competitividad (CTM2009CTM2012-38720-C03-01)
- Ministerio de Educación for a predoctoral scholarship (AP2010-4278)
This publication has 62 references indexed in Scilit:
- Metabolite Profiling of Alzheimer's Disease Cerebrospinal FluidPLOS ONE, 2012
- Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's diseaseJournal of Neuroinflammation, 2011
- Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectivesMetabolomics, 2010
- Deficient Liver Biosynthesis of Docosahexaenoic Acid Correlates with Cognitive Impairment in Alzheimer's DiseasePLOS ONE, 2010
- FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Data processing for mass spectrometry-based metabolomicsJournal of Chromatography A, 2007
- Mass spectrometry‐based metabolomicsMass Spectrometry Reviews, 2006
- Age-related changes in glutathione and glutathione-related enzymes in rat brainBrain Research, 2006
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984